These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 34104098)

  • 1. β3-integrin Leu33Pro gain of function variant does not modulate inflammatory activity in human derived macrophages in diabetes.
    Helmer P; Damm E; Schiekofer S; Roomp K; Schneider JG
    Int J Med Sci; 2021; 18(12):2661-2665. PubMed ID: 34104098
    [No Abstract]   [Full Text] [Related]  

  • 2. Integrin beta3 Leu33Pro homozygosity and risk of cancer.
    Bojesen SE; Tybjaerg-Hansen A; Nordestgaard BG
    J Natl Cancer Inst; 2003 Aug; 95(15):1150-7. PubMed ID: 12902444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Gain-of-Function Integrin β3 Pro33 Variant Alters the Serotonin System in the Mouse Brain.
    Dohn MR; Kooker CG; Bastarache L; Jessen T; Rinaldi C; Varney S; Mazalouskas MD; Pan H; Oliver KH; Velez Edwards DR; Sutcliffe JS; Denny JC; Carneiro AMD
    J Neurosci; 2017 Nov; 37(46):11271-11284. PubMed ID: 29038237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin beta3 Leu33Pro polymorphism increases BRCA1-associated ovarian cancer risk.
    Jakubowska A; Gronwald J; Menkiszak J; Górski B; Huzarski T; Byrski T; Edler L; Lubinski J; Scott RJ; Hamann U
    J Med Genet; 2007 Jun; 44(6):408-11. PubMed ID: 17220212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrin beta3 Leu33Pro polymorphism and risk of hip fracture: 25 years follow-up of 9233 adults from the general population.
    Tofteng CL; Bach-Mortensen P; Bojesen SE; Tybjaerg-Hansen A; Hyldstrup L; Nordestgaard BG
    Pharmacogenet Genomics; 2007 Jan; 17(1):85-91. PubMed ID: 17264806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of ICAM-1 and β3 integrin gene variations in patients with brain tumors.
    Yilmaz U; Zeybek U; Kahraman OT; Kafadar AM; Toptas B; Yamak N; Celik F; Yaylim I
    Asian Pac J Cancer Prev; 2013; 14(10):5929-34. PubMed ID: 24289603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI.
    Verdoia M; Secco GG; Barbieri L; Cassetti E; Schaffer A; Sinigaglia F; Marino P; Suryapranata H; De Luca G;
    Platelets; 2014; 25(5):367-72. PubMed ID: 24283589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy.
    Björck S; Blohmé G; Sylvén C; Mulec H
    Nephrol Dial Transplant; 1997; 12 Suppl 2():67-70. PubMed ID: 9269704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrin beta3 Leu33Pro polymorphism and breast cancer risk: a population-based case-control study in Germany.
    Wang-Gohrke S; Chang-Claude J
    Breast Cancer Res Treat; 2004 Dec; 88(3):231-7. PubMed ID: 15609125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PPAR gamma 2 Pro12Ala variant predicts ESRD and mortality in patients with type 1 diabetes and diabetic nephropathy.
    Jorsal A; Tarnow L; Lajer M; Ek J; Hansen T; Pedersen O; Parving HH
    Mol Genet Metab; 2008 Jul; 94(3):347-51. PubMed ID: 18467141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leu33Pro (PlA) polymorphism of integrin beta3 modulates platelet Src pY418 and focal adhesion kinase pY397 phosphorylation in response to abnormally high shear stress.
    Huynh K; Nguyen TH; Nguyen PT; Tran NQ; Vo VT; Gyenes M; Stoldt VR
    Blood Coagul Fibrinolysis; 2018 Sep; 29(6):488-495. PubMed ID: 29965811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Integrin beta3 Leu33Pro homozygosity and risk of cancer.
    Wang-Gohrke S; Chang-Claude J
    J Natl Cancer Inst; 2005 May; 97(10):778-9; author reply 779-80. PubMed ID: 15900047
    [No Abstract]   [Full Text] [Related]  

  • 13. Aquaporin 11 variant associates with kidney disease in type 2 diabetic patients.
    Choma DP; Vanacore R; Naylor H; Zimmerman IA; Pavlichenko A; Pavlichenko A; Foye L; Carbone DP; Harris RC; Dikov MM; Tchekneva EE
    Am J Physiol Renal Physiol; 2016 Mar; 310(5):F416-25. PubMed ID: 26719361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet PIA1/PIA2 polymorphism and the risk of periprocedural myocardial infarction in patients with acute coronary syndromes undergoing coronary angioplasty.
    Verdoia M; Secco GG; Cassetti E; Schaffer A; Barbieri L; Perrone-Filardi P; Marino P; Suryapranata H; Sinigaglia F; De Luca G
    Blood Coagul Fibrinolysis; 2014 Mar; 25(2):107-13. PubMed ID: 24480844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No association of breast cancer risk with integrin beta3 (ITGB3) Leu33Pro genotype.
    Bojesen SE; Tybjaerg-Hansen A; Axelsson CK; Nordestgaard BG
    Br J Cancer; 2005 Jul; 93(1):167-71. PubMed ID: 15970922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes.
    Neugebauer S; Baba T; Watanabe T
    Diabetes; 2000 Mar; 49(3):500-3. PubMed ID: 10868974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of alleles of polymorphic variants Leu33Pro and Leu66Arg gene ITGB3 among inhabitants of Siberia].
    Goncharova IA; Babushkina NP; Minaĭcheva LI; Markova VV; Kulish EV; Salakhov RR; Makeeva OA; Puzyrev VP
    Genetika; 2013 Aug; 49(8):1008-12. PubMed ID: 25474888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between apolipoprotein E polymorphism and nephropathy in Iranian diabetic patients.
    Karimoei M; Pasalar P; Mehrabzadeh M; Daneshpour M; Shojaee M; Forouzanfar K; Razi F
    Saudi J Kidney Dis Transpl; 2017; 28(5):997-1002. PubMed ID: 28937055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human peroxisome proliferator-activated receptor gamma2 (PPARgamma2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes.
    Caramori ML; Canani LH; Costa LA; Gross JL
    Diabetes; 2003 Dec; 52(12):3010-3. PubMed ID: 14633865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PlA polymorphism of integrin beta 3 differentially modulates cellular migration on extracellular matrix proteins.
    Sajid M; Vijayan KV; Souza S; Bray PF
    Arterioscler Thromb Vasc Biol; 2002 Dec; 22(12):1984-9. PubMed ID: 12482823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.